Is it necessary to perform control diagnostic 131I whole body scanafter remmant ablation in differentiated thyroid carcinoma patients who have stimulated Tg levels under 2 ng/ml?

Introduction Differentiated thyroid carcinoma (DTC) is a common malignancy with excellent survival rates [1]. Post surgical thyroid remnant ablation and suppression of thyroid-stimulating hormone (TSH) is a key element in treatment for DTC patients [2,3]. Life long follow-up of patients is important because recurrences may occur [4–6]. The follow-up of these